Explore

Trendline Trendline
LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy

LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy

LIB Therapeutics Launches LEROCHOL in U.S. with Affordable Pricing Strategy
Trendline Trendline
Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market
Trendline Trendline
ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug
Trendline Trendline
Merck and Amgen Focus on Cholesterol Reduction to Combat Heart Disease

Merck and Amgen Focus on Cholesterol Reduction to Combat Heart Disease

Merck and Amgen Focus on Cholesterol Reduction to Combat Heart Disease
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Trendline Trendline
IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy

IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy

IMMEDIATE Therapeutics Expands Leadership to Advance IMT-358 for Ischemic Therapy
Trendline Trendline
Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims

Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims

Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims
Trendline Trendline
Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations
Trendline Trendline
Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform

Trisk Bio and NanoMosaic Partner to Enhance AAV Analytics with Tessie Platform
Trendline Trendline
FDA Delays Decision on Biogen and Eisai's Subcutaneous Alzheimer's Therapy, Impacting Treatment Timeline

FDA Delays Decision on Biogen and Eisai's Subcutaneous Alzheimer's Therapy, Impacting Treatment Timeline

FDA Delays Decision on Biogen and Eisai's Subcutaneous Alzheimer's Therapy, Impacting Treatment Timeline
Trendline Trendline
Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features